PURE Bioscience, Inc. PURE

Full chart Compare
Set alert

Price alert · PURE

All alert types
0.07 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.0621 Day range 0.075
0.04 52-week range 0.10
YTD
+75.00%
1 year
+16.67%
Market cap
9.81M
Revenue (ttm)
1.29M
EPS (ttm)
-0.02
Shares out
64.82M
YTD return
+75.00%
1-year return
+16.67%
Volume
7.70K
Avg volume
29.86K
Open
0.0621
Previous close
0.07
Day's range
0.0621 – 0.075
52-week range
0.04 – 0.10
Beta
-1.99
Analysts
Buy

1Y +0.0150 (+25.00%)

0.04000.06000.08000.1000Dec 25Feb 26May 26Jul 26Sep 260.0750

Key statistics

Enterprise value
115.38M
PEG ratio
0.00
Price / sales
50.29
Price / book
12.99
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
127.80%
Free cash flow
-1.07M
Total cash
5.19M
Total debt
0
Return on equity
-388.09%
Short % of float
2.08%
50-day average
1.02
200-day average
1.03

Financials — quick view

All financials
PURE Revenue — quarterly 407.00K
2019-06-302019-09-302019-12-312020-03-312020-06-302020-09-302020-12-312021-03-312021-06-302021-09-302021-12-312022-03-312022-06-302022-09-302022-12-312023-03-31
PURE Net income — quarterly -876.00K
2019-06-302019-09-302019-12-312020-03-312020-06-302020-09-302020-12-312021-03-312021-06-302021-09-302021-12-312022-03-312022-06-302022-09-302022-12-312023-03-31
PURE EPS — quarterly -0.01
2019-06-302019-09-302019-12-312020-03-312020-06-302020-09-302020-12-312021-03-312021-06-302021-09-302021-12-312022-03-312022-06-302022-09-302022-12-312023-03-31

Earnings

PURE recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 16, 2024Oct 1, 20240.00-0.01——
Oct 29, 2024Jul 1, 20240.00-0.01——
Jun 14, 2024Apr 1, 20240.00-0.01——
Mar 18, 2024Jan 1, 20240.00-0.01——
Dec 14, 2023Oct 1, 20230.00-0.01——
Oct 30, 2023Jul 1, 20230.00-0.03——

Upgrades / downgrades

PURE analyst upgrades and downgrades
DateFirmActionFromTo
Apr 7, 2011C.K. Cooperinit—Buy

About PURE Bioscience, Inc.

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a antimicrobial food processing aid for use in poultry processing and produce processing; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces; and SILVÉRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.

Sector
Basic Materials
Industry
Chemicals - Major Diversified
Country
United States
Website
purebio.com

News

Your note

Sign in to keep a note on PURE — it syncs with the Stock Master app.

Insider holders

PURE insider holders
InsiderRelationLatest transactionDateShares held
ELLIOTT MARK STUARTOfficerDisposition (Non Open Market)Apr 5, 201672,350
FRANCHISE BRANDS, LLCBeneficial Owner (10% or more)PurchaseOct 22, 201518,666,666
LAMBERT HENRY R.OfficerAcquisition (Non Open Market)Jul 30, 2015842,857
LEE TOM YDirectorOption ExerciseMay 19, 20163,899,337

Institution ownership

PURE institution ownership
Holder% heldSharesValueReported
Goldman Capital Management, Inc.1.36%879,184958.31KSep 29, 2016

Fund ownership

PURE fund ownership
Holder% heldSharesValueReported
Starboard Investment Tr-SCS Tactical Allocation Fund0.52%335,026304.87KAug 30, 2016
AMG Managers Essex Small/Micro Cap Growth Fd0.20%130,148136.66KJun 29, 2016